KarX-EC + KarXT for autism spectrum disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Autistic Disorder

Why this status

  1. 16 Dec 2025: Trial registered, NCT07284745
  2. 6 Oct 2026: Trial started, NCT07284745

The trials

NCT07284745: A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism

State
Under way
Phase
Phase 3
People
176 planned
Started
6 Oct 2026
Primary completion
6 Aug 2029
Arms
KarXT + KarX-EC Arm
Results
None posted
  1. 16 Dec 2025: Trial registered
  2. 6 Oct 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.